Search

Your search keyword '"Alvaro Henrique Ingles Garces"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Alvaro Henrique Ingles Garces" Remove constraint Author: "Alvaro Henrique Ingles Garces"
27 results on '"Alvaro Henrique Ingles Garces"'

Search Results

1. Radiotherapy alone in locally advanced cervical cancer: a palliative treatment? Real-world data

2. Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil

Catalog

Books, media, physical & digital resources

3. Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature review

4. Radiotherapy alone in locally advanced cervical cancer: a palliative treatment? Real-world data

5. First-in-human study of AT13148, a dual ROCK-AKT inhibitor in patients with solid tumors

6. A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials

7. Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors

8. Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer

9. Current and emerging systemic therapies for cutaneous metastatic melanoma

10. Exploiting HPV-Induced Carcinogenesis for a Rational Drug Development in Cervical Cancer

11. A Review of mTOR Pathway Inhibitors in Gynecologic Cancer

12. First-Line Paclitaxel and Carboplatin in Persistent/Recurrent or Advanced Cervical Cancer

13. Topotecan Use for Second-Line Treatment in Patients with Recurrent or Metastatic Cervical Cancer at Brazilian National Cancer Institute (INCA)

14. Patterns of Care and Outcome of Elderly Women Diagnosed With Cervical Cancer in the Developing World

15. A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I

16. Phase 1/2a study of once daily oral BAL101553, a novel tumor checkpoint controller (TCC), in adult patients with advanced solid tumors

17. Approach and Management of Cervical Cancer

18. Abstract 3081: Precision medicine for patients with advanced small cell lung cancer treated with novel therapeutic agents in a phase I clinical trials unit

19. Adherence to novel oral anticancer therapies in the phase I setting: The Royal Marsden experience

20. Phase 1/2a trial of daily oral BAL101553, a novel tumor checkpoint controller (TCC), in advanced solid tumors

21. An investigator-initiated phase I study of ONX-0801, a first-in-class alpha folate receptor targeted, small molecule thymidylate synthase inhibitor in solid tumors

22. A phase I study to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activities of daily oral BAL101553, a novel tumor checkpoint controller (TCC) in adult patients with progressive or recurrent glioblastoma (GBM) or high-grade glioma

23. A phase I study of SRA737 (formerly known as CCT245737) administered orally in patients with advanced cancer

24. A phase I study of oral SRA737 (formerly CCT245737) given in combination with gemcitabine plus cisplatin or gemcitabine alone in patients with advanced cancer

25. Treatment of ovarian cancer beyond chemotherapy: are we hitting the target?

26. Prevalence and risk factors of HBV, HCV and HIV infections among cervical cancer patients in a tertiary care institution in Brazil

27. Thromboembolic events in breast cancer patients: A large series